Get access

How Can Erythropoeitin-Stimulating Agent Use be Reduced in Chronic Dialysis Patients?

The “Forgotten Adjunct Therapy”: The Link Between ESA Use and Control of Hyperparathyroidism in Chronic Kidney Disease

Authors


Address correspondence to: Dr. Christopher T Chan, 200 Elizabeth Street, 8N room 842, Toronto, ON, M5G 2C4, Canada, Tel.: 416-340-3073, Fax: 416-340-4999, or e-mail: christopher.chan@uhn.ca

Ancillary